Centogene N.V. (CNTG)
Centogene Statistics
Share Statistics
Centogene has 29M shares outstanding. The number of shares has increased by 4.07% in one year.
Shares Outstanding | 29M |
Shares Change (YoY) | 4.07% |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | 7.71% |
Shares Floating | 11.78M |
Failed to Deliver (FTD) Shares | 148 |
FTD / Avg. Volume | 0.07% |
Short Selling Information
The latest short interest is 98.23K, so 0.34% of the outstanding shares have been sold short.
Short Interest | 98.23K |
Short % of Shares Out | 0.34% |
Short % of Float | 0.84% |
Short Ratio (days to cover) | 1.01 |
Valuation Ratios
The PE ratio is -0.85 and the forward PE ratio is null. Centogene's PEG ratio is undefined.
PE Ratio | -0.85 |
Forward PE | n/a |
PS Ratio | 0.63 |
Forward PS | null |
PB Ratio | -1.2 |
P/FCF Ratio | -0.89 |
PEG Ratio | undefined |
Enterprise Valuation
Centogene N.V. has an Enterprise Value (EV) of 51.49M.
EV / Earnings | -1.45 |
EV / Sales | 1.06 |
EV / EBITDA | -2.65 |
EV / EBIT | -1.74 |
EV / FCF | -1.51 |
Financial Position
The company has a current ratio of 1.02, with a Debt / Equity ratio of -3.18.
Current Ratio | 1.02 |
Quick Ratio | 0.96 |
Debt / Equity | -3.18 |
Total Debt / Capitalization | 145.86 |
Cash Flow / Debt | -0.39 |
Interest Coverage | -3.62 |
Financial Efficiency
Return on equity (ROE) is 1.41% and return on capital (ROIC) is -54.24%.
Return on Equity (ROE) | 1.41% |
Return on Assets (ROA) | -0.46% |
Return on Capital (ROIC) | -54.24% |
Revenue Per Employee | $126,395.83 |
Profits Per Employee | $-92,531.25 |
Employee Count | 384 |
Asset Turnover | 0.63 |
Inventory Turnover | 12.7 |
Taxes
Income Tax | 287K |
Effective Tax Rate | -0.01 |
Stock Price Statistics
The stock price has increased by -73.6% in the last 52 weeks. The beta is -0.67, so Centogene's price volatility has been lower than the market average.
Beta | -0.67 |
52-Week Price Change | -73.6% |
50-Day Moving Average | 0.3 |
200-Day Moving Average | 0.66 |
Relative Strength Index (RSI) | 41.49 |
Average Volume (20 Days) | 220.75K |
Income Statement
In the last 12 months, Centogene had revenue of 48.54M and earned -35.53M in profits. Earnings per share was -1.27.
Revenue | 48.54M |
Gross Profit | 17.25M |
Operating Income | -29.66M |
Net Income | -35.53M |
EBITDA | -19.43M |
EBIT | -29.66M |
Earnings Per Share (EPS) | -1.27 |
Balance Sheet
The company has 18.17M in cash and 80.41M in debt, giving a net cash position of -62.23M.
Cash & Cash Equivalents | 18.17M |
Total Debt | 80.41M |
Net Cash | -62.23M |
Retained Earnings | -177.36M |
Total Assets | 77.16M |
Working Capital | 653K |
Cash Flow
In the last 12 months, operating cash flow was -31.75M and capital expenditures -2.28M, giving a free cash flow of -34.03M.
Operating Cash Flow | -31.75M |
Capital Expenditures | -2.28M |
Free Cash Flow | -34.03M |
FCF Per Share | -1.22 |
Margins
Gross margin is 35.54%, with operating and profit margins of -61.11% and -73.21%.
Gross Margin | 35.54% |
Operating Margin | -61.11% |
Pretax Margin | -72.62% |
Profit Margin | -73.21% |
EBITDA Margin | -40.04% |
EBIT Margin | -61.11% |
FCF Margin | -70.11% |
Dividends & Yields
CNTG does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | -384.85% |
FCF Yield | -361.04% |
Analyst Forecast
Currently there are no analyst rating for CNTG.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | -3.91 |
Piotroski F-Score | 3 |